SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY

<p><span style="font-family: Calibri;"><span style="font-size: medium;">Background. Venomenhal® (V) is a new brand of</span></span></p><p><span style="font-family: Calibri; font-size: medium;">Hymenoptera venom allergen fo...

Full description

Bibliographic Details
Main Authors: Mitja Košnik, Ema Mušič, Angelika Sager
Format: Article
Language:English
Published: Slovenian Medical Association 2001-10-01
Series:Zdravniški Vestnik
Subjects:
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/2553
id doaj-adcd07f9d7ab48f4842072826e23d1fd
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Mitja Košnik
Ema Mušič
Angelika Sager
spellingShingle Mitja Košnik
Ema Mušič
Angelika Sager
SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
Zdravniški Vestnik
allergen extracts
Hymenoptera venom allergy
immunotherapy
safety
author_facet Mitja Košnik
Ema Mušič
Angelika Sager
author_sort Mitja Košnik
title SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
title_short SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
title_full SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
title_fullStr SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
title_full_unstemmed SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
title_sort safety of venomenhal® venom in maintenance hymenoptera venom immunotherapy
publisher Slovenian Medical Association
series Zdravniški Vestnik
issn 1318-0347
1581-0224
publishDate 2001-10-01
description <p><span style="font-family: Calibri;"><span style="font-size: medium;">Background. Venomenhal® (V) is a new brand of</span></span></p><p><span style="font-family: Calibri; font-size: medium;">Hymenoptera venom allergen for diagnosis and immunotherapy</span></p><p><span style="font-family: Calibri; font-size: medium;">of venom allergy. We studied the safety of switching the</span></p><p><span style="font-family: Calibri; font-size: medium;">patients treated with other brands of venom to V.</span></p><p><span style="font-family: Calibri; font-size: medium;"> </span></p><p><span style="font-family: Calibri;"><span style="font-size: medium;">Methods. We performed duplicate skin prick tests with V and</span></span></p><p><span style="font-family: Calibri; font-size: medium;">ALK Reless® (R) venom extract (100 μg/ml) in 68 patients (50</span></p><p><span style="font-family: Calibri; font-size: medium;">males, 42 ± 15 years) on maintenance immunotherapy with</span></p><p><span style="font-family: Calibri; font-size: medium;">honey bee (26) or wasp (42) venom. On two consecutive maintenance</span></p><p><span style="font-family: Calibri; font-size: medium;">injection days 53 patients received in random order</span></p><p><span style="font-family: Calibri; font-size: medium;">either 100 μg of R or V venom.</span></p><p><span style="font-family: Calibri; font-size: medium;"> </span></p><p><span style="font-family: Calibri;"><span style="font-size: medium;">Results. Weal diameter in skin prick tests (mean ± st.dev.) were</span></span></p><p><span style="font-family: Calibri; font-size: medium;">3.9 ± 1.1 mm (V) and 4.1 ± 1.0 mm (R) for bee venom (NS)</span></p><p><span style="font-family: Calibri; font-size: medium;">and 3.4 ± 1.0 mm (V) and 3.9 ± 1.2 mm (R) for wasp venom (p</span></p><p><span style="font-family: Calibri; font-size: medium;">&lt; 0.01). Local reaction 30 minutes after maintenance injection</span></p><p><span style="font-family: Calibri; font-size: medium;">were 6.1 ± 1.7 cm (V) and 5.4 ± 2.5 cm (R) for bee venom</span></p><p><span style="font-family: Calibri; font-size: medium;">(NS) and 5.1 ± 1.8 cm (V) and 6.1 ± 1.8 cm (R) for wasp venom</span></p><p><span style="font-family: Calibri; font-size: medium;">(p &lt; 0.05).</span></p><p><span style="font-family: Calibri; font-size: medium;">Late local reactions (LLR) and tiredness (T) on the day of injection</span></p><p><span style="font-family: Calibri; font-size: medium;">and 24 hours after injection were equally distributed</span></p><p><span style="font-family: Calibri; font-size: medium;">among both groups and were mild (LLR on the day of injection:</span></p><p><span style="font-family: Calibri; font-size: medium;">38% of patients [V] vs. 43% [R]. LLR after 24 hours: 28%</span></p><p><span style="font-family: Calibri; font-size: medium;">[V] vs. 28% [R]. T on the day of injection: 21% [V] vs. 23% [R].</span></p><p><span style="font-family: Calibri; font-size: medium;">T after 24 hours: 0% [V] vs. 6% [R]).</span></p><p><span style="font-family: Calibri; font-size: medium;"> </span></p><p><span style="font-family: Calibri;"><span style="font-size: medium;">Conclusions. V was at least as safe as A. There were no adverse</span></span></p><p><span style="font-family: Calibri; font-size: medium;">reactions due to switching from one brand to another. Slightly</span></p><p><span style="font-family: Calibri; font-size: medium;">but significantly smaller weal in skin prick tests and immediate</span></p><p><span style="font-family: Calibri; font-size: medium;">local reactions might be due to lesser potency or better</span></p><p><span style="font-family: Calibri; font-size: medium;">purification of V wasp extract.</span></p>
topic allergen extracts
Hymenoptera venom allergy
immunotherapy
safety
url http://vestnik.szd.si/index.php/ZdravVest/article/view/2553
work_keys_str_mv AT mitjakosnik safetyofvenomenhalvenominmaintenancehymenopteravenomimmunotherapy
AT emamusic safetyofvenomenhalvenominmaintenancehymenopteravenomimmunotherapy
AT angelikasager safetyofvenomenhalvenominmaintenancehymenopteravenomimmunotherapy
_version_ 1725743606582476800
spelling doaj-adcd07f9d7ab48f4842072826e23d1fd2020-11-24T22:29:40ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242001-10-0170101974SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPYMitja Košnik0Ema Mušič1Angelika Sager2University Clinic of Respiratory and Allergic Diseases 4204 Golnik SloveniaUniversity Clinic of Respiratory and Allergic Diseases 4204 Golnik SlovenHAL ALLERGIE GMBH Düsseldorf Germany<p><span style="font-family: Calibri;"><span style="font-size: medium;">Background. Venomenhal® (V) is a new brand of</span></span></p><p><span style="font-family: Calibri; font-size: medium;">Hymenoptera venom allergen for diagnosis and immunotherapy</span></p><p><span style="font-family: Calibri; font-size: medium;">of venom allergy. We studied the safety of switching the</span></p><p><span style="font-family: Calibri; font-size: medium;">patients treated with other brands of venom to V.</span></p><p><span style="font-family: Calibri; font-size: medium;"> </span></p><p><span style="font-family: Calibri;"><span style="font-size: medium;">Methods. We performed duplicate skin prick tests with V and</span></span></p><p><span style="font-family: Calibri; font-size: medium;">ALK Reless® (R) venom extract (100 μg/ml) in 68 patients (50</span></p><p><span style="font-family: Calibri; font-size: medium;">males, 42 ± 15 years) on maintenance immunotherapy with</span></p><p><span style="font-family: Calibri; font-size: medium;">honey bee (26) or wasp (42) venom. On two consecutive maintenance</span></p><p><span style="font-family: Calibri; font-size: medium;">injection days 53 patients received in random order</span></p><p><span style="font-family: Calibri; font-size: medium;">either 100 μg of R or V venom.</span></p><p><span style="font-family: Calibri; font-size: medium;"> </span></p><p><span style="font-family: Calibri;"><span style="font-size: medium;">Results. Weal diameter in skin prick tests (mean ± st.dev.) were</span></span></p><p><span style="font-family: Calibri; font-size: medium;">3.9 ± 1.1 mm (V) and 4.1 ± 1.0 mm (R) for bee venom (NS)</span></p><p><span style="font-family: Calibri; font-size: medium;">and 3.4 ± 1.0 mm (V) and 3.9 ± 1.2 mm (R) for wasp venom (p</span></p><p><span style="font-family: Calibri; font-size: medium;">&lt; 0.01). Local reaction 30 minutes after maintenance injection</span></p><p><span style="font-family: Calibri; font-size: medium;">were 6.1 ± 1.7 cm (V) and 5.4 ± 2.5 cm (R) for bee venom</span></p><p><span style="font-family: Calibri; font-size: medium;">(NS) and 5.1 ± 1.8 cm (V) and 6.1 ± 1.8 cm (R) for wasp venom</span></p><p><span style="font-family: Calibri; font-size: medium;">(p &lt; 0.05).</span></p><p><span style="font-family: Calibri; font-size: medium;">Late local reactions (LLR) and tiredness (T) on the day of injection</span></p><p><span style="font-family: Calibri; font-size: medium;">and 24 hours after injection were equally distributed</span></p><p><span style="font-family: Calibri; font-size: medium;">among both groups and were mild (LLR on the day of injection:</span></p><p><span style="font-family: Calibri; font-size: medium;">38% of patients [V] vs. 43% [R]. LLR after 24 hours: 28%</span></p><p><span style="font-family: Calibri; font-size: medium;">[V] vs. 28% [R]. T on the day of injection: 21% [V] vs. 23% [R].</span></p><p><span style="font-family: Calibri; font-size: medium;">T after 24 hours: 0% [V] vs. 6% [R]).</span></p><p><span style="font-family: Calibri; font-size: medium;"> </span></p><p><span style="font-family: Calibri;"><span style="font-size: medium;">Conclusions. V was at least as safe as A. There were no adverse</span></span></p><p><span style="font-family: Calibri; font-size: medium;">reactions due to switching from one brand to another. Slightly</span></p><p><span style="font-family: Calibri; font-size: medium;">but significantly smaller weal in skin prick tests and immediate</span></p><p><span style="font-family: Calibri; font-size: medium;">local reactions might be due to lesser potency or better</span></p><p><span style="font-family: Calibri; font-size: medium;">purification of V wasp extract.</span></p>http://vestnik.szd.si/index.php/ZdravVest/article/view/2553allergen extractsHymenoptera venom allergyimmunotherapysafety